Skip to main content
TRANS GENIC GROUP INC. logo

TRANS GENIC GROUP INC. — Investor Relations & Filings

Ticker · 2342 ISIN · JP3635720000 T Professional, scientific and technical activities
Open in API
Filings indexed 70 across all filing types
Latest filing 2026-05-29 M&A Activity
Country JP Japan
Listing T 2342

About TRANS GENIC GROUP INC.

https://transgenic-group.co.jp/

TRANS GENIC GROUP INC. is a biotechnology company that operates through two main business segments: Drug Discovery Support and Investment & Consulting. The Drug Discovery Support division provides comprehensive services across the entire drug development pipeline, from basic research to non-clinical and clinical trials. Core services include the contract production of genetically modified animals, particularly mice, using genome editing technologies like CRISPR/Cas9. The company also specializes in contract antibody production, glycosylation analysis, and the supply of model mice. The Investment & Consulting segment focuses on M&A, business succession, and providing advisory and support services for business revitalization.

Recent filings

Filing Released Lang Actions
臨時報告書
M&A Activity Classification · 85% confidence The document is a Japanese “臨時報告書” (extraordinary report) filed under the Financial Instruments and Exchange Act to disclose that the board resolved on absorb-type mergers of two specific subsidiaries. It provides detailed merger structure, shareholding changes, schedule, and legal approvals, matching an M&A announcement. This falls squarely under “M&A Activity” (Code: TAR) rather than an annual or interim report, earnings release, or simple report publication notice.
2026-05-29 Japanese
当社連結子会社による当社孫会社の吸収合併および連結子会社間の吸収合併に関するお知らせ
M&A Activity Classification · 90% confidence The document is a formal announcement by a listed company (Transgenic Group) regarding the board resolution to effect internal mergers (absorption-type) among its consolidated subsidiaries and sub-subsidiaries. It outlines merger structure, schedules, company details, and financial impacts, which clearly pertains to M&A activity. It is not a full annual or interim report, nor an earnings release or regulatory certification. Therefore it should be classified as M&A Activity (TAR).
2026-05-27 Japanese
臨時報告書
Regulatory Filings Classification · 85% confidence The document is a Japanese "臨時報告書" (Timely Disclosure Report) filed under the Financial Instruments and Exchange Law, detailing material events affecting the company’s financial condition (e.g., debt forgiveness, impairment losses, GLP non-compliance compensation). It is not a periodic interim or annual report, nor is it an announcement of publication; rather it is an ad hoc regulatory filing similar to a Form 8-K/6-K. No specific category for ad hoc event reports exists, so it defaults to Regulatory Filings (RNS).
2026-05-14 Japanese
「エクソンヒト化マウス」に関する米国特許査定のお知らせ
Regulatory Filings
2026-04-22 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report (like a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements. H1 28
2025-11-13 Japanese
半期報告書－第28期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Fukuoka Local Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow analysis for the interim period (April 1, 2025, to September 30, 2025). As it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2026
2025-11-13 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.